Users Stopping Anti-Obesity Injections Put On Pounds Four Times Faster Compared to Those on Conventional Diets

Illustration of medical injection and weighing machine
Obesity treatment involves long-term strategies.

A recent study reveals that patients who stop using new weight-loss injections like Mounjaro or Wegovy can put back on shed pounds at a significantly accelerated pace than those who stop traditional diet and exercise regimens.

Published data in a major health publication shows that while overweight people frequently drop a large proportion of their body weight while undergoing treatment, the weight is regained at an average rate of 0.8 kg per month once they quit.

"Individuals purchasing these drugs should be informed of the danger of fast weight regain when the treatment is stopped," warns expert Dr. Susan Jebb.

Such speed of regain suggests a return to original weight within about 18 months.

Comparing Approaches

The analysis, which examined 37 of trials involving thousands of patients, contrasted the outcomes of GLP-1 agonists with other pills.

The team emphasize that people who shed pounds through diet and exercise typically have a more gradual creep back—around 0.1 kg a month—once they finish.

Understanding the Fast Regain

Doctors propose the way of the injections explains the accelerated weight return.

The injections copy a body's own chemical called GLP-1, which controls hunger.

"Artificially providing GLP-1 levels far above than the body's typical production might result in the body to generate a reduced amount of its own natural GLP-1, and could diminish sensitivity to its effects," explained Dr. Adam Collins, a dietetics specialist.

"Discontinuation of this hormone supplement results in appetite is uncontrolled, making excessive eating far more likely."

A Chronic Disease?

Health authorities suggest the jabs for individuals with weight-linked health risks, alongside recommended lifestyle changes.

A number of clinicians say that, considering the high risk of relapse, the therapy is often long-term.

This view is reinforced by drug manufacturers, who say that the findings "highlight the persistent character of obesity," comparing it to managing conditions like diabetes.

User Experiences

People who have come off the medication explain a intense return of hunger.

"It was like something that goes on and you become ravenous," described one woman.

This difficulty is worsened if individuals have not established lasting dietary or behavioural changes during treatment.

Widespread Adoption

Recent estimates suggest that a significant number of people in the UK have used weight-loss jabs in the last 12 months, with demand being substantial.

  • Adoption is greater among females than men.
  • The 40s and 50s age group shows the highest usage rates.
  • A large proportion access the drugs through private prescriptions rather than public health services.

Finally, experts stress that while the jabs are effective tools for weight loss, they are not a permanent solution and long-term success hinges on combined behavioural support.

Raymond Wong
Raymond Wong

A dedicated writer and life coach passionate about helping others unlock their potential through mindful practices and positive thinking.